Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 1,719 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Positive control Clear all

Conditions: Diabetes Mellitus, Type 2, Depressive Symptoms, Depression
Interventions: Cognitive Behavioral Therapy, Exercise, Group Discussions - Ongoing Support; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Male only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Chronic Spinal Cord Injury, Neurogenic Bladder
Interventions: High Dose, Low dose; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Anxiety
Interventions: Dream Yoga Inspired Intervention, Sleep Health Enhancement program; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: Evanston, Illinois • Charlottesville, Virginia

Conditions: Overactive Bladder, Overactive Detrusor, Urgency-Frequency Syndrome, UTI
Interventions: Extended Urine Culture; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Lymphoma, Refractory B-Cell Lymphoma, Lymphoma, B-Cell, DLBCL NOS, High-grade B-cell Lymphoma, Multiple Myeloma
Interventions: Activities of Daily Living/ADLs, Instrumental Activity of Daily Living, Timed Up and Go, Cognition, Geriatric Depression Scale, Social Support, Brief Test of Attention, Trail Making Test, Controlled Oral Word Association Test, Hopkins Verbal Learning Test-Revised, Blood draw; Behavioral · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 60 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Irritation/Irritant
Interventions: Hypochlorous acid solution 106 mg/L, 0.1% (w/v) Sodium Lauryl Sulfate, 0.9% Physiological Saline, USP; Drug
Lead sponsor: Pulmatrix Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Butte, Montana

Conditions: Vaping, E Cig Use, Prescription Drug Misuse
Interventions: School-based Hybrid Intervention to Prevent Vaping and Prescription Drug Misuse; Behavioral
Lead sponsor: Christopher Williams; Industry
Eligibility: 7 Years to 11 Years
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Posttraumatic Stress Disorder
Interventions: Abbreviated, Intensive, Multi-Couple Group Cognitive-Behavioral Conjoint Therapy for PTSD, Prevention and Relationship Education Program; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Gingivitis
Interventions: 0.454% stannous fluoride, 0.76% sodium monofluorophosphate, 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM; Drug
Lead sponsor: Procter and Gamble; Industry
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Neuroendocrine Tumors
Interventions: 177Lu-edotreotide PRRT, Everolimus, Amino-Acid Solution; Drug · Other
Lead sponsor: ITM Solucin GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2029
U.S. locations: 6
States / cities: Gilbert, Arizona • Stanford, California • Tampa, Florida + 3 more

Conditions: Pregnancy in Adolescence, HIV
Interventions: Making Proud Choices, Making Proud Choices AND Getting To Outcomes; Behavioral
Lead sponsor: RAND; Other
Eligibility: 10 Years to 14 Years
Enrollment: 909 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 4
States / cities: Auburn, Alabama • Huntsville, Alabama • Montgomery, Alabama + 1 more

Conditions: Schnitzler Syndrome, Urticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder)
Interventions: 80 mg RPH-104, Placebo; Biological · Drug
Lead sponsor: R-Pharm Overseas, Inc.; Industry
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Denver, Colorado • Rochester, Minnesota • Portland, Oregon + 1 more

Conditions: Healthy
Interventions: Pirtobrutinib, Placebo, Moxifloxacin; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Dallas, Texas • Madison, Wisconsin

Conditions: Anthrax Infection
Interventions: AVA, Ad4-PA-1, Ad4-PA-GPI-1; Biological
Lead sponsor: Emergent BioSolutions; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 4
States / cities: Kansas City, Kansas • Silver Spring, Maryland • St Louis, Missouri + 1 more

Conditions: Diabetes Mellitus
Interventions: IMPaCT Community Health Worker, Digital health monitoring with financial incentives, Usual Care; Behavioral · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: PreDiabetes
Interventions: Episodic Future Thinking, Daily Check in; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 74 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Buffalo, New York • Roanoke, Virginia

Conditions: Sleep Disorder; Breathing-Related, Pain, Sleep Apnea, Obstructive Sleep Apnea, Sleep, Sleep Disorder, Chronic Pain, Opioid Use
Interventions: Positive Airway Pressure (PAP); Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Transient Tachypnea of the Newborn
Interventions: High Flow Nasal Cannula, Bubble Nasal CPAP; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: Up to 24 Hours
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV (Human Immunodeficiency Virus), Sexually Transmitted Diseases
Interventions: Reality Check, Physical Activity Attention Control; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 24 Years
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Body Image, Eating Disorder, Obesity, Yoga
Interventions: Yoga; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 26 Years · Female only
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Healthy
Interventions: ALXN2050, ALXN2050-matching Placebo, Moxifloxacin, Moxifloxacin-matching Placebo; Drug
Lead sponsor: Alexion Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Prescription Drug Abuse, Substance Abuse, Substance Use (Drugs, Alcohol)
Interventions: LST High School Hybrid; Behavioral
Lead sponsor: National Health Promotion Associates, Inc.; Industry
Eligibility: 14 Years to 18 Years
Enrollment: 1,804 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: White Plains, New York

Conditions: AML, MDS
Interventions: SOC + TSC-101, Control, SOC + TSC-100; Drug · Other
Lead sponsor: TScan Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 21
States / cities: Duarte, California • Aurora, Colorado • Denver, Colorado + 16 more

Conditions: Sleep Apnea Syndromes
Interventions: CPAP; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation

Feasibility of a Mental-Health Intervention Based on Contemplative Sleep Practices

Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections

Study of CAR-T Therapy in Older Patients

21 Day Cumulative Skin Irritation of RUT058-60

A Hybrid Program to Prevent Substance Use Risk Among Upper Elementary School Students Using a Positive Youth Development Approach

Intensive Multi-Couple Therapy for PTSD Versus Relationship Education in Military Couples

A Bleeding-Model Clinical Study

Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

Enhancing Quality Interventions Promoting Healthy Sexuality

Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants

A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines

Using Digital Health, Financial Incentives, and Community Health Worker Support to Change Health Behavior

Weight Loss for Prediabetes Using Episodic Future Thinking

Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids

High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation

Reality Check: An HIV Risk Reduction Serial Drama

The Effects of Yoga on Body Image in College Women

A Study of the Cardiac Effects of ALXN2050 in Healthy Adults

A High School Program for Preventing Prescription Drug Misuse

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA)

Effects of CPAP on Diet, Physical Activity, and Cardiovascular Risk